Asbestos Claims Management Corp. & National Gypsum Asbestos Trust Claims
Asbestos bodily-injury liabilities associated with the former National Gypsum Company are handled through the NGC Bodily Injury Trust. The history is important: the original National Gypsum Company entered Chapter 11 in 1990, its operating business and National Gypsum name were transferred to a newly formed company under the 1993 reorganization, and the former debtor was renamed Asbestos Claims Management Corporation (ACMC). A later ACMC reorganization established the NGC Bodily Injury Trust to resolve remaining asbestos bodily-injury liabilities of Old NGC/ACMC. The Trust’s current official FAQ states a 40% Payment Percentage.
National Gypsum Asbestos Trust Facts
| Current bodily-injury trust | NGC Bodily Injury Trust |
|---|---|
| Historical debtor | National Gypsum Company (Old NGC) |
| Post-1993 debtor name | Asbestos Claims Management Corporation (ACMC) |
| Old NGC Chapter 11 filing | October 28, 1990 |
| 1993 Plan confirmation | March 9, 1993 |
| ACMC later Chapter 11 filing | August 19, 2002 |
| ACMC Plan confirmation | August 6, 2003 |
| Current Payment Percentage | 40% |
| Mesothelioma ER Allowed Liquidated Value | $22,500 |
| Mesothelioma IR Baseline ALV | $45,000 |
| Mesothelioma Extraordinary Claim maximum ALV | $180,000 |
| Claim processing | Expedited Review (ER) and Individualized Review (IR) |
| Current status | Active |
National Gypsum and ACMC History
The official Trust history states that Old National Gypsum was incorporated in Delaware in 1925 and manufactured or sold building and construction products, some of which contained asbestos. Old NGC and its parent filed Chapter 11 on October 28, 1990.
The bankruptcy court confirmed the 1993 Plan on March 9, 1993. Under that Plan, a new Delaware corporation purchased the operating assets and Gold Bond Building Products business, including the National Gypsum Company name. Old NGC survived the merger with its parent and was renamed Asbestos Claims Management Corporation.
The 1993 Plan created the NGC Settlement Trust to fund Old NGC asbestos liabilities. After later financial and litigation developments, ACMC filed another Chapter 11 plan on August 19, 2002. That Plan was confirmed on August 6, 2003 and established the NGC Bodily Injury Trust to resolve the remaining asbestos bodily-injury liabilities of Old NGC/ACMC.
This distinction matters: today’s operating National Gypsum Company is the reorganized business created under the 1993 Plan. The Trust addresses liabilities assigned to it from Old NGC/ACMC; the page does not imply that every product or activity of the modern company creates a Trust claim.
Allowed Liquidated Values
The NGC Bodily Injury Trust uses Allowed Liquidated Values (ALVs) rather than the Scheduled/Average/Maximum terminology used by many other asbestos trusts. The current official FAQ publishes the following values:
| Disease | ER ALV | IR Baseline ALV | Extraordinary Claim Maximum ALV |
|---|---|---|---|
| Mesothelioma | $22,500 | $45,000 | $180,000 |
| Lung Cancer | $3,750 | $7,500 | $30,000 |
| Other Cancer | $1,600 | $3,200 | $12,800 |
| Non-Malignant I | $1,000 | $2,000 | $8,000 |
| Non-Malignant II | $500 | $1,000 | $4,000 |
| Non-Malignant III | $250 | Not available | Not available |
The FAQ identifies the ER ALV as 50% of the IR baseline and the Extraordinary Claim ceiling as 400% of the IR baseline. Non-Malignant III claims may only be allowed as Expedited Review claims.
Need help now? Call 800.291.0963
Live chat available 24/7, 365 days a year.
Submit Your Case
Current 40% Payment Percentage
The Trust’s current official FAQ states that the NGCBIT Payment Percentage is 40%. After an Allowed Claimant returns a properly executed Release & Indemnity, the Trust pays the ALV multiplied by the Payment Percentage then in effect.
The Trust explains that the Payment Percentage is based on anticipated Trust assets and forecast asbestos claims so present and future claimants can receive an equivalent share of available assets. Payments are generally scheduled monthly, although the Trust can adjust the schedule when volume warrants.
Mathematical illustration only — not a guaranteed payment. A Mesothelioma ER ALV of $22,500 × 40% = $9,000. A Mesothelioma IR baseline ALV of $45,000 × 40% = $18,000. The $180,000 Extraordinary Claim ceiling × 40% = $72,000, but that final figure is only a mathematical ceiling illustration and does not mean a claimant qualifies as Extraordinary or will receive that amount.
Expedited and Individualized Review
The Trust processes both Expedited Review (ER) and Individualized Review (IR) claims. Both are processed in the order received under the CRP’s first-in, first-out procedure.
ER uses the published ER Allowed Liquidated Value when the claim satisfies the applicable medical, exposure and other criteria. IR allows a more individualized evaluation and uses the applicable baseline ALV as the reference point under the Claims Resolution Procedures.
Except for Non-Malignant III, the Trust permits an in-process claim to be changed from ER to IR. Paid claims can be changed from ER to IR in connection with a disease upgrade when the required additional medical evidence is supplied.
Medical and Exposure Evidence
The official FAQ states that claimants must provide documentation supporting both the claimed asbestos-related disease and the claimed exposure to NGC asbestos product or products.
The Trust’s Claims Resolution Procedures and Restated Exposure Policies govern whether exposure evidence is sufficient. A verified work history may come from verified interrogatory answers or a claimant interview and exposure-document review accompanied by a signed verification page.
The Trust also maintains medical-evidence policies, including restrictions on evidence from certain physicians. Because those policies can be updated, claimants should use the Trust’s current documents rather than relying on an older diagnosis or exposure checklist.
Filing Deadlines and Tolling
The Trust’s deadline rules differ depending on whether a claim is malignant or nonmalignant, diagnosis date, death date, applicable jurisdiction and tolling events.
For malignant claims where diagnosis or death occurred after June 16, 1997, the official FAQ states a three-year period after the date of death, subject to applicable tolling rules. Nonmalignant claims diagnosed on or after June 16, 2000 generally use three years after the later of the March 31, 2005 tolling expiration or diagnosis, again subject to the Trust’s tolling provisions.
The FAQ also describes tolling while an asbestos claim against another defendant is pending in the tort system and while a claim is pending with the NGC Bodily Injury Trust. Because limitation questions depend heavily on individual facts and jurisdiction, these provisions should not be treated as a universal filing deadline for every claimant.
Current Claim Processing
The NGC Bodily Injury Trust remains active. Its official website provides current claim forms, filing instructions, exposure policies, deficiency procedures and electronic claim services.
The Trust permits online data entry, electronic spreadsheet submissions and paper claims. A claimant without an attorney must submit a paper claim form rather than file electronically.
Incomplete submissions are placed in an Incomplete status. The current FAQ states that the filing firm generally has 365 days to supply missing required information before the submission becomes Rejected.
No sufficiently current audited 2025 or 2026 financial statement establishing current total assets, cumulative claims paid and lifetime dollars paid was located in the official public materials reviewed for this build. Those figures are therefore omitted.
Confirmed Primary Sources for Trust Facts
No law-firm or lead-generation website was used as factual authority for this page. Primary Trust materials reviewed include:
- Official NGC Bodily Injury Trust website.
- Official NGC Bodily Injury Trust history.
- Official Trust FAQ containing current ALVs, Payment Percentage, filing deadlines and claim procedures.
- Official Eighth Amended Claims Resolution Procedures.
- Official Trust documents and policies.
- Official claim forms and filing materials.
Related Asbestos Trust Fund Resources
Asbestos Trust Fund Information
Filing and Eligibility
Payments and Trust Rules
Frequently Asked Questions About the National Gypsum Asbestos Trust
What trust handles Old National Gypsum asbestos bodily-injury claims?
The NGC Bodily Injury Trust resolves remaining qualifying asbestos bodily-injury liabilities of Old National Gypsum and Asbestos Claims Management Corporation.
Why is Asbestos Claims Management Corporation connected to National Gypsum?
Under the 1993 reorganization, the operating National Gypsum business and name went to a new corporation. Old National Gypsum survived and was renamed Asbestos Claims Management Corporation.
What is the current NGC Bodily Injury Trust Payment Percentage?
The current official Trust FAQ states that the Payment Percentage is 40%.
What is the mesothelioma Allowed Liquidated Value?
The current FAQ lists $22,500 for Expedited Review, a $45,000 Individualized Review baseline ALV and a $180,000 Extraordinary Claim maximum ALV.
What does 40% of the mesothelioma ER ALV equal?
$22,500 multiplied by 40% equals $9,000. This is a mathematical illustration only — not a guaranteed payment.
Does the Trust offer Individualized Review?
Yes. The Trust processes both Expedited Review and Individualized Review claims under its Claims Resolution Procedures.
What evidence is required to file?
The Trust requires documentation supporting the asbestos-related disease and documentation supporting exposure to NGC asbestos products.
Is the NGC Bodily Injury Trust still active?
Yes. The official Trust website currently provides claim filing, deficiency, exposure-policy and payment information.
Get Help Reviewing a National Gypsum or ACMC Asbestos Claim
Call 800.291.0963
Live chat is available 24/7, 365 days a year.
Prior exposure to an Old National Gypsum asbestos-containing product does not automatically establish NGC Bodily Injury Trust eligibility or compensation. Eligibility depends on medical evidence, qualifying product exposure, filing deadlines, applicable Trust procedures and individual circumstances. Compensation is not guaranteed.
⚕️ Legal & Medical Information Disclaimer
This page provides general educational information and is not medical or legal advice. The information does not establish asbestos exposure, diagnosis, causation, liability, claim eligibility or compensation. Medical concerns should be discussed with a qualified healthcare professional, and legal questions should be reviewed with a qualified attorney.